Pavlina Walter explores age management with Michaela Hrdličková, scientist and former biotech executive, revealing how work ability, conscious leadership, and data-driven people care shape sustainable performance and the future of work.

Pavlina explores the gap between healthcare innovation’s promise and proof, offering investors a clear, evidence-based framework on due diligence, AI evaluation, prevention-focused strategy, and how disciplined decision-making drives long-term value.

My conversation with Jiri Raska revealed the real challenge in European biotech: not the science, but the lack of integrated execution. Mid-size CROs with deep analytical and clinical expertise are becoming essential partners, bridging gaps and accelerating therapies to patients.

My conversation with MedTech leader Jiri Pavlicek reaffirmed that Europe’s future in healthcare innovation depends on a mindset of curiosity, resilience, and values, not just regulation. With confidence and evidence-driven leadership, Europe can lead in AI and preventive care.

Healthcare is shifting from treatment to prevention. AI, biosensors, and community health tools are redefining care as continuous, personal, and equitable, turning technology into a partner for human wellbeing.

To scale meaningful healthcare innovation, teams must integrate clinical, regulatory, and payer expertise from day one. Pavlina Walter shares why global readiness is not a future milestone but a founding principle for medtech success.

Agung je nezisková organizace založená Pavlínou Walter a Lenkou Fuentes na podporu vzdělávání a zdravotní péče dětí v Indonésii. Transparentně pomáhá rodinám na Bali a přináší dětem šanci na zdravý a důstojný život.

Evropští výrobci zdravotnických prostředků čelí přísným pravidlům MDR a EU AI Act, která zpomalují inovace v oblasti AI. Model PCCP americké FDA ukazuje, jak propojit bezpečnost s flexibilitou. Evropa musí zjednodušit rámec, aby chránila pacienty a zůstala konkurenceschopná.

AI se stává pevnou součástí klinické praxe na hlavních farmaceutických trzích. Studie GlobalData mapuje přínosy i bariéry její adopce mezi 531 lékaři a ukazuje, jak AI mění diagnostiku, personalizovanou léčbu a administrativu.

Umělá inteligence globálně mění zdravotnické prostředky. Pavlína Walter z GCP-Service International věří v budoucnost českých inovací

Tesomet shows promising results in reducing hyperphagia and weight in patients with Prader-Willi syndrome. Early data from a Phase 2a study highlights its potential as an effective, safe therapy addressing urgent unmet medical needs.